# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001746473-23-000053
Filing Date
2023-08-09
Accepted
2023-08-09 16:09:19
Documents
74
Period of Report
2023-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | plrx-20230630.htm iXBRL | 10-Q | 1272935
2 | EX-31.1 CEO CERTIFICATION | plrx-20230630xex311.htm | EX-31.1 | 10445
3 | EX-31.2 CFO CERTIFICATION | plrx-20230630xex312.htm | EX-31.2 | 10413
4 | EX-32.1 CEO AND CFO CERTIFICATION | plrx-20230630xex321.htm | EX-32.1 | 7294
| Complete submission text file | 0001746473-23-000053.txt |  | 5813192

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | plrx-20230630.xsd | EX-101.SCH | 46674
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | plrx-20230630_cal.xml | EX-101.CAL | 50492
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | plrx-20230630_def.xml | EX-101.DEF | 212716
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | plrx-20230630_lab.xml | EX-101.LAB | 508890
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | plrx-20230630_pre.xml | EX-101.PRE | 357809
68 | EXTRACTED XBRL INSTANCE DOCUMENT | plrx-20230630_htm.xml | XML | 621991

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39303 | Film No.: 231155197
SIC: 2834 Pharmaceutical Preparations